🧠 AI clinical summary is being generated for this article and will appear shortly.
Source
NICE
Published
25 Mar 2026
Last Indexed
25 Mar 2026
Specialty
Diabetes / Metabolic

NICE NG17 covers the management of type 1 diabetes, including insulin regimens, blood glucose monitoring technologies, and management of complications.

Key Recommendations

  • Offer multiple daily injection (basal-bolus) insulin regimen as first choice
  • Continuous subcutaneous insulin infusion (CSII) for T1DM if MDI not effective
  • Flash glucose monitoring (FreeStyle Libre) for all adults with T1DM
  • Continuous glucose monitoring with real-time alerts for hypoglycaemia unawareness
  • HbA1c target ≤48 mmol/mol (6.5%) for adults without significant hypoglycaemia
  • Structured education (DAFNE) for all adults at diagnosis and ongoing
ClinicalIQ Editorial Note: This guideline summary is indexed from NICE. Always refer to the full guideline for complete recommendations. Last indexed: 25 Mar 2026
Share: 𝕏 Twitter/X 🔗 LinkedIn View on NICE ↗

More in Diabetes / Metabolic

NICE
Type 2 Diabetes in Adults: Management (NICE NG28, 2024 Update)
25 Mar 2026
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic…
25 Mar 2026
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver…
25 Mar 2026